Alpine Immune Sciences - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Alpine Immune Sciences M&A Summary

Alpine Immune Sciences has acquired 1 company of its own.

Alpine Immune Sciences has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Alpine Immune Sciences Ownership

Who owns Alpine Immune Sciences?

Alpine Immune Sciences is owned by Vertex Pharmaceuticals. It was acquired on April 10, 2024.

Alpine Immune Sciences Business Overview

Where is Alpine Immune Sciences headquartered?

Alpine Immune Sciences is headquartered in Seattle, Washington.

What is Alpine Immune Sciences’ revenue?

Alpine Immune Sciences disclosed revenue of 59M USD for 2023 and 30M USD for 2022.

How many employees does Alpine Immune Sciences have?

Alpine Immune Sciences has 142 employees.

What sector is Alpine Immune Sciences in?

Alpine Immune Sciences is a life science company.

When was Alpine Immune Sciences founded?

Alpine Immune Sciences was founded in 2007.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 2

Alpine Immune Sciences

Alpine Immune Sciences, Inc.

188 East Blaine Street, Suite 200,
Seattle, Washington 98102
United States,
(206) 788-4545

Alpine Immune Sciences is focused on developing novel protein-based immunotherapies using its proprietary variant immunoglobulin domain (vIgD™) platform technology. The vIgD platform is designed to interact with multiple targets, including many present in the immune synapse. Alpine’s vIgDs are developed using a unique process known as directed evolution, which can produce proteins capable of either enhancing or diminishing an immune response and thereby may apply therapeutically to both oncology and inflammatory diseases. Alpine Immune Sciences was founded in 2007 and is based in Seattle, Washington.

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0

Most Recent M&A

Company Date Value Type
Nivalis Therapeutics, Inc. 2017-04-18 - Merger
Boulder, Colorado ·
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  Colorado 1 - - -
Total 1 - - -

Top M&A Advisors

Legal Deals
Ascent Law Partners

 Subscribe to unlock this and 204,239
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.6K Private Equity Firms
  • 196K M&A Transactions
  • 200K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 77K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.